Citizens JMP lowered the firm’s price target on Raymond James (RJF) to $175 from $190 and keeps an Outperform rating on the shares. The recovery in Financial Services business momentum, like in Investment Banking, which started in 2024 and had been accelerating, is now in jeopardy, the analyst tells investors in a research note. Earnings season matters a lot less than the macro right now, the firm says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RJF:
- Raymond James price target lowered to $181 from $201 at BofA
- Raymond James price target lowered to $150 from $180 at Citi
- Positive Growth Prospects and Strategic Positioning Support Buy Rating for Raymond James Financial
- Raymond James Reports February 2025 Operating Data
- Raymond James reports February-end assets under administration $1.58T